Table 1 Baseline characteristics of the overall study cohort

Demographics

 Age, years (IQR)

63 [54–69]

 Female, n (%)

783 (46)

 Diabetes duration, years (IQR)

10 [5–19]

 Hypertension, n (%)

1135 (67)

 Dyslipidaemia, n (%)

1152 (68)

 Smoking, n (%)

339 (20)

 BMI, kg/m² (IQR)

28.7 [25.4–32.7]

Cardiovascular disease

 PCI, n (%)

66 (4)

 PAD, n (%)

173 (10)

 CeVD, n (%)

99 (6)

 CABG, n (%)

62 (4)

Medications

 Statins, n (%)

764 (45)

 Acetylsalicylic acid, n (%)

634 (38)

 Insulin, n (%)

888 (53)

 Oral antidiabetics, n (%)

984 (58)

Laboratory parameters

 NT-proBNP, pg/ml (IQR)

122 [59–266]

 Albumin/creatinine ratio, mg/mmol (IQR)

0.87 [0.35–2.94]

 eGFR, ml/min (IQR)

72.7 [60.3–85.3]

 LDL cholesterol, mg/dl (IQR)

102 [82–123]

 HbA1c, % (IQR)

7.2 [6.5–8.1]